A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection

The design and selection of new pharmaceutical dosage forms involves the careful consideration and balancing of a quality target product profile against technical challenges and development feasibility. Paediatric dosage forms present particular complexity due to the diverse patient population, pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2012-10, Vol.435 (2), p.115-123
Hauptverfasser: Sam, Tom, Ernest, Terry B., Walsh, Jennifer, Williams, Julie L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 2
container_start_page 115
container_title International journal of pharmaceutics
container_volume 435
creator Sam, Tom
Ernest, Terry B.
Walsh, Jennifer
Williams, Julie L.
description The design and selection of new pharmaceutical dosage forms involves the careful consideration and balancing of a quality target product profile against technical challenges and development feasibility. Paediatric dosage forms present particular complexity due to the diverse patient population, patient compliance challenges and safety considerations of this vulnerable population. This paper presents a structured framework for assessing the comparative benefits and risks of different pharmaceutical design options against pre-determined criteria relating to (1) efficacy, (2) safety and (3) patient access. This benefit/risk framework has then been applied to three hypothetical, but realistic, scenarios for paediatric dosage forms in order to explore its utility in guiding dosage form design and formulation selection. The approach allows a rigorous, systematic and qualitative assessment of the merits and disadvantages of each dosage form option and helps identify mitigating strategies to modify risk. The application of a weighting and scoring system to the criteria depending on the specific case could further refine the analysis and aid decision-making. In this paper, one case study is scored for illustrative purposes. However, it is acknowledged that in real development scenarios, the generation of actual data considering the very specific situation for the patient/product/developer would come into play to drive decisions on the most appropriate dosage form strategy.
doi_str_mv 10.1016/j.ijpharm.2012.05.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1318693480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517312005091</els_id><sourcerecordid>1318693480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-e3999582737c0878233b37d6091f18d9f4966c0859abef205e5fc83097d87d6f3</originalsourceid><addsrcrecordid>eNqFkb2O1DAUhS0EYoeFRwBc0iTrnzi2KzRa8SetRAFbWx7netZDEgc7s4iOlpo35ElwyCyi28rF-e651-cg9JySmhLaXhzqcJhubBpqRiiriagJax6gDVWSV7yR7UO0IVyqSlDJz9CTnA-EkJZR_hidMdayVimxQT-3eAcj-DBfpJC_YDtNKVp3g-f4zaYu4ww9uDmM-1WaUrAz4L-brYPjHJztcRez3QP2MQ0Z__7xC2_HBe-LOIc4LgKeLHRlNgX3P37nH8en6JG3fYZnp_ccXb998_nyfXX18d2Hy-1V5RrG5gq41looJrl0REnFON9x2bVEU09Vp32j27YoQtsdeEYECO8UJ1p2qmCen6NXq2_5zdcj5NkMITvoeztCPGZDOVWt5o0i96OkXEIZUbqgYkVdijkn8KYkNdj0vUBmKcwczKkwsxRmiDClsDL34rTiuBug-zd111ABXq6At9HYfSnJXH8qDoIUF0HpYvF6JaCkdhsgmewCjK7EnUq0povhniP-ABQntSc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1095812089</pqid></control><display><type>article</type><title>A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Sam, Tom ; Ernest, Terry B. ; Walsh, Jennifer ; Williams, Julie L.</creator><creatorcontrib>Sam, Tom ; Ernest, Terry B. ; Walsh, Jennifer ; Williams, Julie L. ; on behalf of the European Paediatric Formulation Initiative (EuPFI) ; European Paediatric Formulation Initiative (EuPFI)</creatorcontrib><description>The design and selection of new pharmaceutical dosage forms involves the careful consideration and balancing of a quality target product profile against technical challenges and development feasibility. Paediatric dosage forms present particular complexity due to the diverse patient population, patient compliance challenges and safety considerations of this vulnerable population. This paper presents a structured framework for assessing the comparative benefits and risks of different pharmaceutical design options against pre-determined criteria relating to (1) efficacy, (2) safety and (3) patient access. This benefit/risk framework has then been applied to three hypothetical, but realistic, scenarios for paediatric dosage forms in order to explore its utility in guiding dosage form design and formulation selection. The approach allows a rigorous, systematic and qualitative assessment of the merits and disadvantages of each dosage form option and helps identify mitigating strategies to modify risk. The application of a weighting and scoring system to the criteria depending on the specific case could further refine the analysis and aid decision-making. In this paper, one case study is scored for illustrative purposes. However, it is acknowledged that in real development scenarios, the generation of actual data considering the very specific situation for the patient/product/developer would come into play to drive decisions on the most appropriate dosage form strategy.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2012.05.024</identifier><identifier>PMID: 22626885</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Approach ; Case studies ; Child ; Compliance ; Decision Making ; Dosage ; Dosage Forms ; drug formulations ; Feasibility studies ; Form ; Humans ; Mitigation ; Paediatric ; patient compliance ; patients ; Pharmaceutical Preparations - administration &amp; dosage ; Risk ; Risk Assessment ; Safety engineering ; Selection ; Vulnerability</subject><ispartof>International journal of pharmaceutics, 2012-10, Vol.435 (2), p.115-123</ispartof><rights>2012 Elsevier B.V.</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-e3999582737c0878233b37d6091f18d9f4966c0859abef205e5fc83097d87d6f3</citedby><cites>FETCH-LOGICAL-c422t-e3999582737c0878233b37d6091f18d9f4966c0859abef205e5fc83097d87d6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2012.05.024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22626885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sam, Tom</creatorcontrib><creatorcontrib>Ernest, Terry B.</creatorcontrib><creatorcontrib>Walsh, Jennifer</creatorcontrib><creatorcontrib>Williams, Julie L.</creatorcontrib><creatorcontrib>on behalf of the European Paediatric Formulation Initiative (EuPFI)</creatorcontrib><creatorcontrib>European Paediatric Formulation Initiative (EuPFI)</creatorcontrib><title>A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The design and selection of new pharmaceutical dosage forms involves the careful consideration and balancing of a quality target product profile against technical challenges and development feasibility. Paediatric dosage forms present particular complexity due to the diverse patient population, patient compliance challenges and safety considerations of this vulnerable population. This paper presents a structured framework for assessing the comparative benefits and risks of different pharmaceutical design options against pre-determined criteria relating to (1) efficacy, (2) safety and (3) patient access. This benefit/risk framework has then been applied to three hypothetical, but realistic, scenarios for paediatric dosage forms in order to explore its utility in guiding dosage form design and formulation selection. The approach allows a rigorous, systematic and qualitative assessment of the merits and disadvantages of each dosage form option and helps identify mitigating strategies to modify risk. The application of a weighting and scoring system to the criteria depending on the specific case could further refine the analysis and aid decision-making. In this paper, one case study is scored for illustrative purposes. However, it is acknowledged that in real development scenarios, the generation of actual data considering the very specific situation for the patient/product/developer would come into play to drive decisions on the most appropriate dosage form strategy.</description><subject>Approach</subject><subject>Case studies</subject><subject>Child</subject><subject>Compliance</subject><subject>Decision Making</subject><subject>Dosage</subject><subject>Dosage Forms</subject><subject>drug formulations</subject><subject>Feasibility studies</subject><subject>Form</subject><subject>Humans</subject><subject>Mitigation</subject><subject>Paediatric</subject><subject>patient compliance</subject><subject>patients</subject><subject>Pharmaceutical Preparations - administration &amp; dosage</subject><subject>Risk</subject><subject>Risk Assessment</subject><subject>Safety engineering</subject><subject>Selection</subject><subject>Vulnerability</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb2O1DAUhS0EYoeFRwBc0iTrnzi2KzRa8SetRAFbWx7netZDEgc7s4iOlpo35ElwyCyi28rF-e651-cg9JySmhLaXhzqcJhubBpqRiiriagJax6gDVWSV7yR7UO0IVyqSlDJz9CTnA-EkJZR_hidMdayVimxQT-3eAcj-DBfpJC_YDtNKVp3g-f4zaYu4ww9uDmM-1WaUrAz4L-brYPjHJztcRez3QP2MQ0Z__7xC2_HBe-LOIc4LgKeLHRlNgX3P37nH8en6JG3fYZnp_ccXb998_nyfXX18d2Hy-1V5RrG5gq41looJrl0REnFON9x2bVEU09Vp32j27YoQtsdeEYECO8UJ1p2qmCen6NXq2_5zdcj5NkMITvoeztCPGZDOVWt5o0i96OkXEIZUbqgYkVdijkn8KYkNdj0vUBmKcwczKkwsxRmiDClsDL34rTiuBug-zd111ABXq6At9HYfSnJXH8qDoIUF0HpYvF6JaCkdhsgmewCjK7EnUq0povhniP-ABQntSc</recordid><startdate>20121005</startdate><enddate>20121005</enddate><creator>Sam, Tom</creator><creator>Ernest, Terry B.</creator><creator>Walsh, Jennifer</creator><creator>Williams, Julie L.</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>C1K</scope></search><sort><creationdate>20121005</creationdate><title>A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection</title><author>Sam, Tom ; Ernest, Terry B. ; Walsh, Jennifer ; Williams, Julie L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-e3999582737c0878233b37d6091f18d9f4966c0859abef205e5fc83097d87d6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Approach</topic><topic>Case studies</topic><topic>Child</topic><topic>Compliance</topic><topic>Decision Making</topic><topic>Dosage</topic><topic>Dosage Forms</topic><topic>drug formulations</topic><topic>Feasibility studies</topic><topic>Form</topic><topic>Humans</topic><topic>Mitigation</topic><topic>Paediatric</topic><topic>patient compliance</topic><topic>patients</topic><topic>Pharmaceutical Preparations - administration &amp; dosage</topic><topic>Risk</topic><topic>Risk Assessment</topic><topic>Safety engineering</topic><topic>Selection</topic><topic>Vulnerability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sam, Tom</creatorcontrib><creatorcontrib>Ernest, Terry B.</creatorcontrib><creatorcontrib>Walsh, Jennifer</creatorcontrib><creatorcontrib>Williams, Julie L.</creatorcontrib><creatorcontrib>on behalf of the European Paediatric Formulation Initiative (EuPFI)</creatorcontrib><creatorcontrib>European Paediatric Formulation Initiative (EuPFI)</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sam, Tom</au><au>Ernest, Terry B.</au><au>Walsh, Jennifer</au><au>Williams, Julie L.</au><aucorp>on behalf of the European Paediatric Formulation Initiative (EuPFI)</aucorp><aucorp>European Paediatric Formulation Initiative (EuPFI)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2012-10-05</date><risdate>2012</risdate><volume>435</volume><issue>2</issue><spage>115</spage><epage>123</epage><pages>115-123</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>The design and selection of new pharmaceutical dosage forms involves the careful consideration and balancing of a quality target product profile against technical challenges and development feasibility. Paediatric dosage forms present particular complexity due to the diverse patient population, patient compliance challenges and safety considerations of this vulnerable population. This paper presents a structured framework for assessing the comparative benefits and risks of different pharmaceutical design options against pre-determined criteria relating to (1) efficacy, (2) safety and (3) patient access. This benefit/risk framework has then been applied to three hypothetical, but realistic, scenarios for paediatric dosage forms in order to explore its utility in guiding dosage form design and formulation selection. The approach allows a rigorous, systematic and qualitative assessment of the merits and disadvantages of each dosage form option and helps identify mitigating strategies to modify risk. The application of a weighting and scoring system to the criteria depending on the specific case could further refine the analysis and aid decision-making. In this paper, one case study is scored for illustrative purposes. However, it is acknowledged that in real development scenarios, the generation of actual data considering the very specific situation for the patient/product/developer would come into play to drive decisions on the most appropriate dosage form strategy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>22626885</pmid><doi>10.1016/j.ijpharm.2012.05.024</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2012-10, Vol.435 (2), p.115-123
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1318693480
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Approach
Case studies
Child
Compliance
Decision Making
Dosage
Dosage Forms
drug formulations
Feasibility studies
Form
Humans
Mitigation
Paediatric
patient compliance
patients
Pharmaceutical Preparations - administration & dosage
Risk
Risk Assessment
Safety engineering
Selection
Vulnerability
title A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms – An application for paediatric dosage form selection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A25%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20benefit/risk%20approach%20towards%20selecting%20appropriate%20pharmaceutical%20dosage%20forms%20%E2%80%93%20An%20application%20for%20paediatric%20dosage%20form%20selection&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Sam,%20Tom&rft.aucorp=on%20behalf%20of%20the%20European%20Paediatric%20Formulation%20Initiative%20(EuPFI)&rft.date=2012-10-05&rft.volume=435&rft.issue=2&rft.spage=115&rft.epage=123&rft.pages=115-123&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2012.05.024&rft_dat=%3Cproquest_cross%3E1318693480%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1095812089&rft_id=info:pmid/22626885&rft_els_id=S0378517312005091&rfr_iscdi=true